Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania
Wael Mansour(Universität Hamburg), Françoise Lunel‐Fabiani(Université d'Angers), Frédéric Le Gal(Sorbonne Université), Alexandra Ducancelle, Faryal Malick(Université de Nouakchott), Ségolène Brichler(Inserm), Ahmad Sidiya(Université de Nouakchott), Elkhalil Ishagh(Université de Nouakchott), Mariama Abdou Chekaraou(Université Sorbonne Paris Nord), Emmanuel Gordien(Inserm), Baïdy Lô(Université de Nouakchott), Pascal Veillon(Université d'Angers)
Cited by 88
Related Papers
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2017|249
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
|Hepatology|2006|238
Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a <i>Deltavirus</i> Genus of at Least Seven Major Clades
|Journal of Virology|2004|221
Eighth Major Clade for Hepatitis Delta Virus
|Emerging infectious diseases|2006|206